$GPAT·8-K

GP-Act III Acquisition Corp. · Apr 29, 4:02 PM ET

Compare

GP-Act III Acquisition Corp. 8-K

Research Summary

AI-generated summary

Updated

GP-Act III Acquisition Corp. Adjourns Meeting to Vote on SPAC Extension

What Happened

  • GP-Act III Acquisition Corp. announced that its April 29, 2026 extraordinary general meeting was convened and then adjourned. Shareholders approved an adjournment vote (21,313,393 for; 8,034,735 against; 1,000 abstentions) and the meeting was rescheduled to May 6, 2026 at 9:00 a.m. Eastern Time.
  • At the Adjourned Meeting shareholders will vote on two proposals: (1) an amendment to extend the company’s deadline to complete a business combination and related actions from May 13, 2026 to November 13, 2026 (the Extension Amendment Proposal); and (2) an amendment to the Investment Management Trust Agreement to extend the trustee’s liquidation date of the trust account from May 13, 2026 to November 13, 2026 (the Trust Amendment Proposal).
  • The company noted that holders who previously elected to redeem their public Class A ordinary shares may reverse those redemption requests by contacting the transfer agent (Continental Stock Transfer & Trust Company) via [email protected] by 9:00 a.m. ET on May 6, 2026.

Key Details

  • Shares outstanding (record date March 24, 2026): 35,937,500; 81.67% were represented at the April 29 meeting (quorum present).
  • Adjournment vote tally: For 21,313,393; Against 8,034,735; Abstentions 1,000.
  • Proposed extension (if approved): new deadline November 13, 2026 (from May 13, 2026).
  • Redemption reversal deadline: 9:00 a.m. Eastern Time on May 6, 2026 via transfer agent email.

Why It Matters

  • This adjournment gives GP-Act III more time to solicit votes needed to approve a SPAC life extension. If the extension proposals are approved, the company and the trust trustee would have until November 13, 2026 to complete a business combination instead of being required to liquidate on May 13, 2026.
  • For investors this affects the timing and likelihood of a business combination and the amount of cash that may remain in the trust (since redemption elections can be reversed). Shareholders should review the Definitive Proxy Statement (filed March 30, 2026) and related SEC filings for full details and risks before voting.

Loading document...